|
|
||||||||
From the Laboratory of Neurogenetics (Dr. Higgins, J.M. Loveless, and A. De Biase) and the Laboratory of Neuromuscular Genetics (Dr. Rosen, S. Goswami, and C. Cozzo), Wadsworth Center, New York State Department of Health, Albany; and the Clinical Neurogenetics Unit (Dr. Higgins) and the Family Studies Unit (L.E. Nee), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
Address correspondence and reprint requests to Dr. Joseph J. Higgins, Director, Center for Human Genetic Studies, Mid-Hudson Family Health Institute/Westchester Medical Center, 279 Main Street, Suite 202, New Paltz, NY 12561; e-mail: jhiggins{at}fpinstitute.org
Objective: To identify the genetic mutation responsible for autosomal dominant spastic paraplegia (HSP) in a large family with a "pure" form of the disorder. Background: The disease locus in most families with HSP is genetically linked to the SPG4 locus on chromosome 2p21-p22. Some of these families have mutations in the splice-site or coding regions of the spastin gene (SPAST). Methods: Linkage and mutational analyses were used to identify the location and the nature of the genetic defect causing the disorder in a large family. After the disease phenotype was linked to the SPG4 locus, all 17 coding regions and flanking intronic sequences of SPAST were analyzed by single-strand conformation polymorphism analysis (SSCP) and compared between affected and normal individuals. Direct sequencing and subcloning methods were used to investigate incongruous mobility shifts. Results:The genomic sequence of SPAST showed a heterozygous fourbase pair deletion (delTAAT) near the 3' splice-site of exon three in all 11 affected individuals but not in 21 normal family members or in 50 unrelated controls (100 chromosomes). Conclusions: This study identifies an atypical intronic microdeletion in SPAST that causes HSP and widens the spectrum of genetic abnormalities that cause the disorder.
This article has been cited by other articles:
![]() |
S.-Y. Park, C.-S. Ki, H.-J. Kim, J.-W. Kim, D. H. Sung, B. J. Kim, and W. Y. Lee Mutation Analysis of SPG4 and SPG3A Genes and Its Implication in Molecular Diagnosis of Korean Patients With Hereditary Spastic Paraplegia Arch Neurol, July 1, 2005; 62(7): 1118 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tang, G. Zhao, K. Xia, Q. Pan, W. Luo, L. Shen, Z. Long, H. Dai, X. Zi, and H. Jiang Three Novel Mutations of the Spastin Gene in Chinese Patients With Hereditary Spastic Paraplegia Arch Neurol, January 1, 2004; 61(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. E. Tallaksen, E. Guichart-Gomez, P. Verpillat, V. Hahn-Barma, M. Ruberg, B. Fontaine, A. Brice, B. Dubois, and A. Durr Subtle Cognitive Impairment but No Dementia in Patients With Spastin Mutations Arch Neurol, August 1, 2003; 60(8): 1113 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Starling, P Rocco, M R Passos-Bueno, J Hazan, S K Marie, and M Zatz Autosomal dominant (AD) pure spastic paraplegia (HSP) linked to locus SPG4 affects almost exclusively males in a large pedigree J. Med. Genet., December 1, 2002; 39(12): e77 - 77. [Full Text] [PDF] |
||||
![]() |
A. Orlacchio, T. Kawarai, E. Rogaeva, Y.Q. Song, A.D. Paterson, G. Bernardi, and P.H. St. George-Hyslop Clinical and genetic study of a large Italian family linked to SPG12 locus Neurology, November 12, 2002; 59(9): 1395 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Yabe, H Sasaki, K Tashiro, T Matsuura, T Takegami, and T Satoh Spastin gene mutation in Japanese with hereditary spastic paraplegia J. Med. Genet., August 1, 2002; 39(8): e46 - 46. [Full Text] [PDF] |
||||
![]() |
I. A. Meijer, C. K. Hand, P. Cossette, D. A. Figlewicz, and G. A. Rouleau Spectrum of SPG4 Mutations in a Large Collection of North American Families With Hereditary Spastic Paraplegia Arch Neurol, February 1, 2002; 59(2): 281 - 286. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |